ERK 2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemERK 2 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-35335
Gene Namemitogen-activated protein kinase 1
Quantity10 µM
Specieshuman
NCBI Full Gene Namemitogen-activated protein kinase 1
NCBI Gene AliasesERK, ERK-2, ERK2, ERT1, MAPK2, NS13, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell linesInternational journal of oncologyJune 1, 2024Kim BR, Kim DY, Tran NL, Kim BG, Lee SI, Kang SH, Min BY, Hur W, Oh SC.sc-37007), GLI1 siRNA (cat. no. sc-37911), AKT siRNA (cat. no. sc-43609), ERK siRNA (cat. no. sc-29307, sc-35335), PCAF siRNA (cat. no. sc-36198) and β-TrCP siRNA (cat. no. sc-37178) were all purchased from Santa Cruz Biotechnology, Inc

(2) ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genesNat CommunDecember 14, 2023Heeyoun Bunch, Deukyeong Kim, Masahiro Naganuma, Reiko Nakagawa, Anh Cong, Jaehyeon Jeong, Haruhiko Ehara, Hongha Vu, Jeong Ho Chang, Matthew J. Schellenberg, et al.sc-37007) and ERK1 siRNA (Cell Signaling Technology, #6436), ERK2 siRNA (Santa Cruz Biotechnology, sc-35335), or both ERK siRNA species. Lipofectamine 2000 (Invitrogen) or FuGENE HD (Promega, E2311) transfection reagent

(3) Pseudomonas aeruginosa-Derived DnaJ Induces the Expression of IL−1β by Engaging the Interplay of p38 and ERK Signaling Pathways in MacrophagesInternational Journal of Molecular SciencesNovember 3, 2023Dae-Kyum Kim, Jin-Won Huh, Hyeonseung Yu, Yeji Lee, Yongxin Jin, Un-Hwan HaUSA) following the manufacturer’s instructions. 4.7. siRNA Transfection siERK1 (#sc-29307), siERK2 (#sc-35335), siCD91 (#sc-40101), siCD40 (#sc-29250), siTLR2 (#sc-40256) were obtained from Santa Cruz Biotechnology

(4) 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosisCancer gene therapyOctober 1, 2023Mu M, Zhang Q, Zhao C, Li X, Chen Z, Sun X, Yu J.FOXO3a (sc-37887-V). The PUMA CRISPR plasmid (sc-400464-KO-2), ERK1 siRNA (sc-29307), and ERK2 siRNA (sc-35335) were also purchased from Santa Cruz (Santa Cruz, CA, USA). All transfections were performed following

(5) EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationNature cell biologyAugust 1, 2022Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, et al.(sc-105312), RhoA (sc-29471), Cdc42 (sc-29256), STAT3 (sc-29493), Shc (sc-29480), ERK1(sc-29307), ERK2 (sc-35335), Sp1 (sc-29487), TAB1(sc-61851), TAK1(sc-36606) and scrambled siRNAs (sc-37007) were obtained from

(6) PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistanceCell death & diseaseJuly 29, 2021Yoon C, Lu J, Ryeom SW, Simon MC, Yoon SS.

(7) MicroRNA‑186‑5p downregulation inhibits osteoarthritis development by targeting MAPK1Molecular medicine reportsApril 1, 2021Li Q, Wu M, Fang G, Li K, Cui W, Li L, Li X, Wang J, Cang Y.(5′-GCCUCCGGCUUCGCACCUCU-3′; Guangzhou RiboBio Co., Ltd.), 0.2 µM MAPK1-small interfering RNA (siRNA; cat no. sc-35335; Santa Cruz Biotechnology, Inc.), 0.2 µM control-siRNA (cat no. sc-36869; Santa Cruz Biotechnology, Inc

(8) Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signalingOncogeneFebruary 1, 2021Lu J, Bang H, Kim SM, Cho SJ, Ashktorab H, Smoot DT, Zheng CH, Ryeom SW, Yoon SS, Yoon C, et al.

(9) Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular SenescenceFrontiers in cardiovascular medicineJanuary 1, 2021Uchikado Y, Ikeda Y, Sasaki Y, Iwabayashi M, Akasaki Y, Ohishi M.knockdown, cells were transfected with ERK1, ERK2, Rab9, or control siRNA (Santa Cruz, Cat #sc-29307, sc-35335, sc-44065, sc-37007) using the siRNA transfection reagent (Santa Cruz, Cat #sc-29528), according to

(10) BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancerCommunications biologyOctober 1, 2020Conciatori F, Bazzichetto C, Amoreo CA, Sperduti I, Donzelli S, Diodoro MG, Buglioni S, Falcone I, Shirasawa S, Blandino G, et al.

(11) ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomasCell death & diseaseApril 23, 2020Huang C, Yoon C, Zhou XH, Zhou YC, Zhou WW, Liu H, Yang X, Lu J, Lee SY, Huang K.

(12) Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myelomaHaematologicaOctober 1, 2019Ramakrishnan VG, Miller KC, Macon EP, Kimlinger TK, Haug J, Kumar S, Gonsalves WI, Rajkumar SV, Kumar SK.

(13) Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethalityCell Death & DiseaseAugust 13, 2019Wenfeng Zhang, Ding Xia, Zhangyun Li, Tao Zhou, Tingting Chen, Zhengping Wu, Weihua Zhou, Zilun Li, Longkun Li, Jie Xusequences targeting Aur-A were used in our previous study; sequences targeting ERK1 (sc-29307) or 2 (sc-35335) were purchased from Santa Cruz and mixed together before use; sequence targeting mTOR is 5′-CUUCGAGACAUGA

(14) Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis InductionJournal of natural productsApril 26, 2019Kawiak A, Domachowska A, Lojkowska E.

(15) 3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 InhibitionFrontiers in pharmacologyJanuary 1, 2019Kawiak A, Domachowska A, Krolicka A, Smolarska M, Lojkowska E.

(16) Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagyTheranosticsJanuary 1, 2019Zhang X, Qi Z, Yin H, Yang G.(YEASEN, Shanghai, China) according to the manufacturer's instructions. SiRNAs for ERK1/2 (sc-29307/ sc-35335) and AKT1/2 (sc-43609) and a control siRNA (sc-37007) were purchased from Santa Cruz Biotech and transfected

(17) CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK PathwayJournal of virologyDecember 15, 2018Wang L, Xie W, Zhang L, Li D, Yu H, Xiong J, Peng J, Qiu J, Sheng H, He X, et al.Santa Cruz, including SP1 siRNA (sc-29487), MEK1/2 siRNA (sc-29396 and sc-35905), ERK1/2 siRNA (sc-29307 and sc-35335), and SREBP1 siRNA (sc-36557). Quantitative RT-PCR. Total cellular RNA was extracted from cells with

(18) EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumoursOncogeneJuly 1, 2018Toosi BM, El Zawily A, Truitt L, Shannon M, Allonby O, Babu M, DeCoteau J, Mousseau D, Ali M, Freywald T, et al.

(19) Natural Polyphenol Chlorogenic Acid Protects Against Acetaminophen-Induced Hepatotoxicity by Activating ERK/Nrf2 Antioxidative PathwayToxicological sciences : an official journal of the Society of ToxicologyMarch 1, 2018Wei M, Zheng Z, Shi L, Jin Y, Ji L.

(20) Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in VitroFrontiers in pharmacologyJanuary 1, 2018Youn DH, Park J, Kim HL, Jung Y, Kang J, Lim S, Song G, Kwak HJ, Um JY.

Be the First to Write a Review!

ERK 2 siRNA (h)

ERK 2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (63)

Reviews

ERK 2 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map